CN100531738C - (11β,17β)-11-(1,3-苯并间二氧杂环戊烯-5-基)-17-羟基-17-(1-丙炔基)雌-4,9-二烯-3-酮在治疗重性抑郁症中的应用 - Google Patents
(11β,17β)-11-(1,3-苯并间二氧杂环戊烯-5-基)-17-羟基-17-(1-丙炔基)雌-4,9-二烯-3-酮在治疗重性抑郁症中的应用 Download PDFInfo
- Publication number
- CN100531738C CN100531738C CNB028210417A CN02821041A CN100531738C CN 100531738 C CN100531738 C CN 100531738C CN B028210417 A CNB028210417 A CN B028210417A CN 02821041 A CN02821041 A CN 02821041A CN 100531738 C CN100531738 C CN 100531738C
- Authority
- CN
- China
- Prior art keywords
- treatment
- org
- patient
- 11beta
- 17beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01204072.1 | 2001-10-26 | ||
EP01204072 | 2001-10-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1582153A CN1582153A (zh) | 2005-02-16 |
CN100531738C true CN100531738C (zh) | 2009-08-26 |
Family
ID=8181136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB028210417A Expired - Fee Related CN100531738C (zh) | 2001-10-26 | 2002-10-21 | (11β,17β)-11-(1,3-苯并间二氧杂环戊烯-5-基)-17-羟基-17-(1-丙炔基)雌-4,9-二烯-3-酮在治疗重性抑郁症中的应用 |
Country Status (27)
Country | Link |
---|---|
US (1) | US20040266863A1 (zh) |
EP (2) | EP1441739B1 (zh) |
JP (1) | JP4647909B2 (zh) |
KR (1) | KR20050038580A (zh) |
CN (1) | CN100531738C (zh) |
AT (2) | ATE317700T1 (zh) |
AU (1) | AU2002348996B2 (zh) |
BR (1) | BR0213466A (zh) |
CA (1) | CA2463446C (zh) |
CY (1) | CY1110173T1 (zh) |
DE (2) | DE60209248D1 (zh) |
DK (1) | DK1652526T3 (zh) |
EC (1) | ECSP045080A (zh) |
ES (1) | ES2319563T3 (zh) |
HK (1) | HK1087357A1 (zh) |
HR (1) | HRP20040370B1 (zh) |
HU (1) | HUP0500070A3 (zh) |
IL (2) | IL161248A0 (zh) |
IS (1) | IS2702B (zh) |
MX (1) | MXPA04003781A (zh) |
NO (1) | NO332978B1 (zh) |
NZ (1) | NZ532429A (zh) |
PL (1) | PL206687B1 (zh) |
PT (1) | PT1652526E (zh) |
RU (1) | RU2302245C2 (zh) |
WO (1) | WO2003037354A1 (zh) |
ZA (1) | ZA200403088B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050080061A1 (en) * | 2003-07-23 | 2005-04-14 | Corcept Therapeutics, Inc. | Antiglucocorticoid therapy for the prevention of neurological damage in premature infants |
EP1814589B1 (en) * | 2004-11-19 | 2015-04-15 | MSD Oss B.V. | Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression |
AU2011236053B2 (en) * | 2004-11-19 | 2014-06-26 | Merck Sharpe & Dohme B.V. | Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression |
CA2649894A1 (en) * | 2006-05-02 | 2007-11-15 | Corcept Therapeutics, Inc. | The use of a glucocorticoid receptor ii antagonist to treat depression in patients taking il-2 |
US8658128B2 (en) | 2011-02-03 | 2014-02-25 | Pop Test Cortisol Llc | System and method for diagnosis and treatment |
WO2012145258A1 (en) * | 2011-04-18 | 2012-10-26 | Pop Test Cortisol Llc | Hair loss treatment |
US8986677B2 (en) * | 2012-07-30 | 2015-03-24 | Pop Test Cortisol Llc | Therapeutic compositions and methods |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4814333A (en) * | 1987-07-28 | 1989-03-21 | The Trustees Of Dartmouth College | Method for treatment of hypercortisolemic, depressed patients |
CN1147520A (zh) * | 1995-08-17 | 1997-04-16 | 阿克佐诺贝尔公司 | 11-(取代的苯基)-雌-4,9-二烯衍生物 |
CN1272788A (zh) * | 1997-10-06 | 2000-11-08 | 利兰·斯坦福青年大学托管委员会 | 治疗糖皮质素功能失调相关性精神病的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19727772A1 (de) * | 1997-06-30 | 1999-01-28 | Forschungszentrum Juelich Gmbh | Magnetflußsensor mit ringförmiger Sonde |
PT1370268E (pt) * | 2001-03-23 | 2009-08-26 | Corcept Therapeutics Inc | Métodos de tratamento de perturbações de stress usando antagonistas específicos dos receptores de glucocorticóides |
JP2005512949A (ja) * | 2001-05-04 | 2005-05-12 | コーセプト セラピューティクス, インコーポレイテッド | グルココルチコイドレセプターに特異的なアンタゴニストを使用して、せん妄を処置する方法 |
DE60229411D1 (de) * | 2001-08-31 | 2008-11-27 | Corcept Therapeutics Inc | Verfahren zur hemmung der verschlechterung der kognitiven leistungsfähigkeit bei erwachsenen mit down-syndrom |
-
2002
- 2002-10-21 WO PCT/EP2002/011732 patent/WO2003037354A1/en not_active Application Discontinuation
- 2002-10-21 MX MXPA04003781A patent/MXPA04003781A/es active IP Right Grant
- 2002-10-21 CA CA2463446A patent/CA2463446C/en not_active Expired - Fee Related
- 2002-10-21 DE DE60209248T patent/DE60209248D1/de not_active Expired - Lifetime
- 2002-10-21 AT AT02781273T patent/ATE317700T1/de active
- 2002-10-21 HU HU0500070A patent/HUP0500070A3/hu unknown
- 2002-10-21 DK DK06101005T patent/DK1652526T3/da active
- 2002-10-21 KR KR1020047006050A patent/KR20050038580A/ko not_active Application Discontinuation
- 2002-10-21 DE DE60230936T patent/DE60230936D1/de not_active Expired - Lifetime
- 2002-10-21 EP EP02781273A patent/EP1441739B1/en not_active Withdrawn - After Issue
- 2002-10-21 PT PT06101005T patent/PT1652526E/pt unknown
- 2002-10-21 BR BR0213466-7A patent/BR0213466A/pt not_active IP Right Cessation
- 2002-10-21 AU AU2002348996A patent/AU2002348996B2/en not_active Ceased
- 2002-10-21 US US10/493,981 patent/US20040266863A1/en not_active Abandoned
- 2002-10-21 IL IL16124802A patent/IL161248A0/xx unknown
- 2002-10-21 RU RU2004116082/15A patent/RU2302245C2/ru not_active IP Right Cessation
- 2002-10-21 ES ES06101005T patent/ES2319563T3/es not_active Expired - Lifetime
- 2002-10-21 JP JP2003539697A patent/JP4647909B2/ja not_active Expired - Fee Related
- 2002-10-21 CN CNB028210417A patent/CN100531738C/zh not_active Expired - Fee Related
- 2002-10-21 AT AT06101005T patent/ATE420649T1/de active
- 2002-10-21 EP EP06101005A patent/EP1652526B1/en not_active Expired - Lifetime
- 2002-10-21 PL PL369261A patent/PL206687B1/pl not_active IP Right Cessation
- 2002-10-21 NZ NZ532429A patent/NZ532429A/en not_active IP Right Cessation
-
2004
- 2004-03-31 IS IS7204A patent/IS2702B/is unknown
- 2004-04-01 IL IL161248A patent/IL161248A/en not_active IP Right Cessation
- 2004-04-22 ZA ZA200403088A patent/ZA200403088B/en unknown
- 2004-04-23 NO NO20041651A patent/NO332978B1/no not_active IP Right Cessation
- 2004-04-23 EC EC2004005080A patent/ECSP045080A/es unknown
- 2004-04-26 HR HRP20040370AA patent/HRP20040370B1/xx not_active IP Right Cessation
-
2006
- 2006-08-29 HK HK06109619.6A patent/HK1087357A1/xx not_active IP Right Cessation
-
2009
- 2009-02-02 CY CY20091100116T patent/CY1110173T1/el unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4814333A (en) * | 1987-07-28 | 1989-03-21 | The Trustees Of Dartmouth College | Method for treatment of hypercortisolemic, depressed patients |
CN1147520A (zh) * | 1995-08-17 | 1997-04-16 | 阿克佐诺贝尔公司 | 11-(取代的苯基)-雌-4,9-二烯衍生物 |
CN1272788A (zh) * | 1997-10-06 | 2000-11-08 | 利兰·斯坦福青年大学托管委员会 | 治疗糖皮质素功能失调相关性精神病的方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2211845B1 (en) | Glucocorticoid receptor antagonists such as mifepristone for treating cushing's syndrome | |
EP1408981B1 (en) | Methods for preventing antipsychotic-induced weight gain | |
CA2504751C (en) | Methods for treating gastroesophageal reflux disease | |
CN100531738C (zh) | (11β,17β)-11-(1,3-苯并间二氧杂环戊烯-5-基)-17-羟基-17-(1-丙炔基)雌-4,9-二烯-3-酮在治疗重性抑郁症中的应用 | |
EP2576582A1 (en) | Treatment of muscular dystrophy | |
US8193172B2 (en) | Methods for the treatment of major depressive disorder using glucocorticoid receptor antagonists | |
CA2459033C (en) | Methods for inhibiting cognitive deterioration in adults with down's syndrome | |
AU2002348996A1 (en) | Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatement of major depressive disorder | |
AU2002335678B2 (en) | Methods for inhibiting cognitive deterioration in adults with down's syndrome | |
AU2002335678A1 (en) | Methods for inhibiting cognitive deterioration in adults with down's syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ORGANON NV Free format text: FORMER OWNER: AKZO NOVEL N.V. CORP. Effective date: 20070126 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20070126 Address after: Holland Applicant after: Organon NV Address before: Holland Arnhem Applicant before: Akzo Nobel N. V. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: POP TEST CORTISOL LLC Free format text: FORMER OWNER: ORGANON NV Effective date: 20110419 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: OSS, NETHERLANDS TO: NEW JERSEY, THE USA |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110419 Address after: new jersey Patentee after: Pop beta cortisol limited liability company Address before: Holland Patentee before: Organon NV |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090826 Termination date: 20141021 |
|
EXPY | Termination of patent right or utility model |